Caxton Associates (New York)’s Exelixis EXEL Stock Holding History

Caxton Associates (New York)’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$1.12M	Sell	33,508 -2,218	-6%	-$72K	0.04%	194
2024 Q3	$927K	Sell	35,726 -37,227	-51%	-$925K	0.03%	256
2024 Q2	$1.64M	Sell	72,953 -65,920	-47%	-$1.46M	0.06%	181
2024 Q1	$3.3M	Buy	138,873 +114,339	+466%	+$2.54M	0.18%	67
2023 Q4	$589K	Buy	+24,534	New	+$533K	0.03%	298
2020 Q4	–	Sell	-11,142	Closed	-$272K	–	197
2020 Q3	$272K	Sell	11,142 -2,965	-21%	-$69.2K	0.03%	214
2020 Q2	$335K	Buy	+14,107	New	+$327K	0.03%	224
2017 Q3	–	Sell	-9,200	Closed	-$227K	–	526
2017 Q2	$227K	Buy	+9,200	New	+$195K	0.01%	456

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Caxton Associates (New York)'s EXEL Position: Q4 2024 in Review

Caxton Associates (New York) reduced its Exelixis (EXEL) stake by 6.2% in Q4 2024, selling an estimated $72K and leaving 33,508 shares worth $1.12M. The position accounts for 0.04% of the portfolio, ranked #194.

Caxton Associates (New York) first reported a position in EXEL in Q2 2017 and has held it in 8 quarters since. The position peaked at $3.3M in Q1 2024. 518 funds tracked by Wall St. Rank hold EXEL as of Q4 2024.

Caxton Associates (New York) held 33,508 shares of Exelixis worth $1.12M as of Q4 2024.
Caxton Associates (New York) sold 2,218 Exelixis shares in Q4 2024, an estimated $72K.
Exelixis made up 0.04% of Caxton Associates (New York)'s portfolio in Q4 2024, its #194 holding.
Caxton Associates (New York) first reported a position in Exelixis in Q2 2017 and has held it in 8 quarters since.
Caxton Associates (New York)'s Exelixis position peaked at $3.3M in Q1 2024.
518 funds tracked by Wall St. Rank held Exelixis as of Q4 2024.

Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.